NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • Impact
    • Steering Committee
    • Promoting equality, diversity and inclusion in research
    • Current Vacancies
    • Stay in Touch
    • Contact Us
  • Research

        • Research Overview
        • Clinical Research Facility
        • Health Economics
        • Ethics in the NIHR Oxford BRC
        • Medical Statistics
        • Infections in Oxfordshire Database (IORD)
        • 15 Research Themes

        • Cancer
        • Cardiovascular Medicine
        • Digital Health from Hospital to Home
        • Gene and Cell Therapy
        • Genomic Medicine
        • Imaging
        • Inflammation across Tissues
        • Life-saving Vaccines
        • Metabolic Experimental Medicine
        • Modernising Medical Microbiology and Big Infection Diagnostics
        • Musculoskeletal
        • Preventive Neurology
        • Respiratory Medicine
        • Surgical Innovation, Technology and Evaluation
        • Translational Data Science
  • Patient and Public Involvement
    • For patients and the public
    • For researchers
    • More information
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Pre-Doctoral Research Fellowships
    • Senior Research Fellowships
    • Doctoral Awards
    • Post-Doctoral Awards
    • Pre-Application Programme
    • Other Funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
    • Success Stories
  • Industry and Partnerships
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Partnerships News
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events

News Archive

You are here: Home > General News Listings

News

Liver problems common among COVID-19 patients, study finds

23 July 2021 · Listed under COVID-19, Inflammation across Tissues, Translational Data Science

A study by Oxford University researchers has found that liver problems are common among patients with COVID-19. Patient data revealed that baseline hypoalbuminemia (an possible indication that the liver is producing low levels of albumin) and rising alkaline phosphatase (ALP), which can be a ... READ MORE

Oxford studies benefit from government funding of long COVID research

19 July 2021 · Listed under COVID-19, Imaging

Image link to post

Thousands of people suffering with long COVID will benefit from new research programmes backed by £19.6 million to help better understand the condition, improve diagnosis and find new treatments. Among the 15 studies that will receive government funding through the National Institute for Health ... READ MORE

COVID-19 risk prediction tool wins national award

16 July 2021 · Listed under COVID-19, Translational Data Science

Image link to post

A COVID-19 risk prediction tool, developed with support from the NIHR Oxford Biomedical Research Centre (BRC) has won the Florence Nightingale Award for Excellence in Healthcare Data Analytics. The QCovid® COVID-19 Population Risk Assessment tool was developed by a cross-organisational team and ... READ MORE

Oxford Cancer launched at the University of Oxford

14 July 2021 · Listed under Cancer

Image link to post

Oxford Cancer has been launched to represent and coordinate cancer research in Oxford. The pan-divisional initiative has been launched at the University of Oxford, bringing together the collective force of cancer research, outreach and care that happen across the city. With more than 900 ... READ MORE

Antiviral drug could be given to more chronic hepatitis B patients, study finds

14 July 2021 · Listed under Modernising Medical Microbiology and Big Infection Diagnostics, Translational Data Science

Image link to post

A study by Oxford University researchers has found that the antiviral drug TDF may benefit a greater number of patients with chronic hepatitis B virus, and that those who are untreated may be at greater risk of liver inflammation and fibrosis. The research was carried out under the auspices of ... READ MORE

“Modest” increase in heart attack hospitalisation rates after years of decline

13 July 2021 · Listed under Cardiovascular Medicine, Translational Data Science

Image link to post

The burden of hospital admission rates due to heart attacks in England rose between 2012 and 2016, despite decades of falling rates, new research suggests. The researchers also found that after 2010-2011, admission rates increased in most age groups. Young women aged 35 to 49 and even younger ... READ MORE

AI replaces contrast dye for fast, cheaper and needle-free cardiac MRI scans

7 July 2021 · Listed under Cardiovascular Medicine, Imaging

Image link to post

A team from Oxford comprising artificial intelligence (AI) scientists, magnetic resonance specialists and cardiologists have developed a new cardiac magnetic resonance (CMR) scan for detecting heart muscle disease. The current ‘gold standard’ for imaging heart muscle disease is CMR, using a ... READ MORE

New Senior Research Fellows named

1 July 2021 · Listed under Cardiovascular Medicine, Imaging, Modernising Medical Microbiology and Big Infection Diagnostics, Musculoskeletal, Other News, Preventive Neurology

Image link to post

The NIHR Oxford BRC has announced the appointment of its latest group of Senior Research Fellows – the third cohort of emerging research leaders to receive the accolade. Like in 2020, this year’s selection process was a coordinated effort by the Oxford BRC and its partners in the NIHR ... READ MORE

Study investigating targeted drug delivery by focused ultrasound for pancreatic cancer opens

1 July 2021 · Listed under Cancer, Surgical Innovation, Technology and Evaluation

Image link to post

University of Oxford researchers have begun recruitment to a study looking at whether chemotherapy medication can reach pancreatic tumours more effectively if encapsulated within a heat-sensitive shell and triggered with focused ultrasound. The Phase I PanDox study, which is supported by the ... READ MORE

Delayed second dose and third doses of the Oxford vaccine lead to heightened immune response to COVID-19

29 June 2021 · Listed under COVID-19, Life-saving Vaccines

Image link to post

A longer delay of up to 45 weeks between the first and second dose of the Oxford-AstraZeneca vaccine leads to enhanced immune response after the second dose, the latest research by the Oxford Vaccine Group has found. They also found that a third dose given more than six months after the second ... READ MORE

  • « Previous Page
  • 1
  • …
  • 29
  • 30
  • 31
  • 32
  • 33
  • …
  • 95
  • Next Page »

News

News Categories

News by Month

See all news

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

Oxford BRC on Social Media

  • Bluesky
  • Facebook
  • LinkedIn
  • YouTube
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2026 NIHR Oxford Biomedical Research Centre